Related Experiment Videos

How to help your patient cope with hearing loss

J H McCartney, G Nadler

|March 1, 1979

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Stereospecificity of myofibrillar calcium sensitivity and PDE inhibition in cardiotonic thiadiazinones.

European journal of medicinal chemistry·2011

Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase.

Farmaco (Societa chimica italiana : 1989)·2001

(2Z,4E)-5-(5,6-dichloro-2-indolyl)-2-methoxy-N-(1,2,2,6,6- pentamethylpiperidin-4-yl)-2,4-pentadienamide, a novel, potent and selective inhibitor of the osteoclast V-ATPase.

Bioorganic & medicinal chemistry letters·1999

Synthesis, electrophysiological properties and analysis of structural requirements of a novel class of antiarrhythmic agents with potassium and calcium channel blocking properties.

Bioorganic & medicinal chemistry·1999

5-(5,6-Dichloro-2-indolyl)-2-methoxy-2,4-pentadienamides: novel and selective inhibitors of the vacuolar H+-ATPase of osteoclasts with bone antiresorptive activity.

Journal of medicinal chemistry·1998

A novel class of cardiotonic agents: synthesis and biological evaluation of 5-substituted 3,6-dihydrothiadiazin-2-ones with cyclic AMP phosphodiesterase inhibiting and myofibrillar calcium sensitizing properties.

Journal of medicinal chemistry·1992

See all related articles